source
- FDA approves Takeda’s narcolepsy drug and the first mRNA flu vaccineThe U.S. Food and Drug Administration has granted approval to a new narcolepsy treatment developed by Takeda, marking a significant addition to the therapeutic options for the sleep disorder. In a…
- Moderna's mRNA flu vaccine mFLUVISA receives FDA approval after earlier filing refusalThe U.S. Food and Drug Administration initially issued a refusal-to-file letter to Moderna's flu vaccine in February, but a few days later reversed that decision and accepted a revised submission f…